James Investment Research Inc Medtronic PLC Transaction History

James Investment Research Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	BUY	$100.58 - $112.38 $3,218 - $3,596	32 New	32 $4,000
Q1 2021 Apr 22, 2021	SELL	$111.18 - $119.74 $699,099 - $752,925	-6,288 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$100.57 - $117.14 $1.4 Million - $1.64 Million	-13,961 Reduced 68.95%	6,288 $737,000
Q3 2020 Oct 23, 2020	SELL	$90.13 - $108.78 $9.5 Million - $11.5 Million	-105,377 Reduced 83.88%	20,249 $2.1 Million
Q2 2020 Jul 24, 2020	SELL	$84.11 - $103.33 $687,767 - $844,929	-8,177 Reduced 6.11%	125,626 $11.5 Million
Q1 2020 Apr 22, 2020	BUY	$72.92 - $121.3 $560,244 - $931,947	7,683 Added 6.09%	133,803 $12.1 Million
Q4 2019 Jan 24, 2020	BUY	$104.49 - $114.54 $2.67 Million - $2.93 Million	25,586 Added 25.45%	126,120 $14.3 Million
Q3 2019 Oct 30, 2019	BUY	$98.02 - $111.18 $9.85 Million - $11.2 Million	100,534 New	100,534 $10.9 Million

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $113B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.